Skip Navigation


Rheumatology Advance Access originally published online on February 28, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
42/4/522    most recent
keg168v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Polgár, A.
Right arrow Articles by Buzás, E. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Polgár, A.
Right arrow Articles by Buzás, E. I.
Related Collections
Right arrow Rheumatoid Arthritis
Right arrow Systemic Lupus Erythematosus and Autoimmunity
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2003; 42: 522-527
© 2003 British Society for Rheumatology

Elevated levels of synovial fluid antibodies reactive with the small proteoglycans biglycan and decorin in patients with rheumatoid arthritis or other joint diseases

A. Polgár1, A. Falus2, É. Koó1,3, I. Ujfalussy1,3, M. Seszták1, I. Szts1, K. Konrád1, L. Hodinka1, É. Bene1,3, Gy. Mészáros1,3, Zs. Ortutay2, É. Farkas2, A. Paksy4 and E. I. Buzás2,

1 National Institute of Rheumatology and Physiotherapy, Budapest,
2 Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest,
3 Polyclinic of Hospitaller Brothers of St John of God in Budapest and
4 Biometry Unit, Semmelweis University, Budapest, Hungary

Objectives. To determine whether patients with rheumatoid arthritis (RA) express humoral immunity to the small proteoglycans biglycan and decorin and to compare the response to that of patients suffering from other joint diseases.

Methods. Serum and synovial fluid IgG and IgM antibody levels were determined by enzyme-linked immunosorbent assay. Antibodies to biglycan and decorin as well as to other known and extensively investigated cartilage matrix components such as type II collagen, aggrecan and fibronectin were investigated. Patients suffering from RA, osteoarthritis (OA), psoriatic arthritis and other seronegative spondylarthropathies were included in the study. Correlation between antibody levels and clinical/laboratory parameters was determined.

Results. Patients with RA expressed an increased humoral immunity to biglycan, while patients with seronegative spondylarthropathies displayed elevated decorin-specific synovial antibody levels compared with OA patients.

Conclusion. These results indicate a significantly higher immunity to small proteoglycans in RA and seronegative spondylarthropathies than in OA suggesting a possible involvement in the pathogenesis of inflammatory rheumatic diseases.

KEY WORDS: Biglycan, Decorin, Aggrecan, Collagen, Fibronectin, Antibody, RA

Correspondence to: E. I. Buzás, Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Nagyvárad tér 4, H-1089, Hungary. E-mail: buzedi{at}dgci.sote.hu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
X. Chang, R. Yamada, A. Suzuki, Y. Kochi, T. Sawada, and K. Yamamoto
Citrullination of fibronectin in rheumatoid arthritis synovial tissue
Rheumatology, November 1, 2005; 44(11): 1374 - 1382.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.